Share This Author
Orienting patients to greater opioid safety: models of community pharmacy-based naloxone
- Traci C. Green, Emily F. Dauria, Jeffrey P. Bratberg, C. Davis, A. Walley
- MedicineHarm Reduction Journal
- 6 August 2015
This case study briefly describes and provides two US state-specific examples of innovative policy models of pharmacy-based naloxone, implemented to reduce overdose events and improve opioid safety: Collaborative Pharmacy Practice Agreements and Pharmacy Standing Orders.
Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment
How the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased are discussed.
Opioid overdose prevention.
- Jeffrey P. Bratberg, Bill McLaughlin, S. Brewster
- Medicine, PsychologyJournal of the American Pharmacists Association…
- 1 September 2015
A pilot randomized control trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose and use of non‐pharmacological strategies for pain relief in addiction treatment patients with chronic pain.
Mobilizing pharmacists to address the opioid crisis: A joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy
- Scott A Coon, Lucas G. Hill, Jeffrey P. Bratberg
- MedicineJACCP: JOURNAL OF THE AMERICAN COLLEGE OF…
- 6 October 2020
This opinion paper challenges the status quo by calling on all pharmacists to embrace evidence‐based opioid stewardship and harm reduction practices, contribute to the medical management of opioid use disorder, and address the misconceptions and prejudices that serve as barriers to effective, compassionate patient care.
An interprofessional education workshop to develop health professional student opioid misuse knowledge, attitudes, and skills.
Missed opportunities for HIV screening in pharmacies and retail clinics.
- C. Dugdale, N. Zaller, Jeffrey P. Bratberg, William Berk, T. Flanigan
- Medicine, Political ScienceJournal of managed care & specialty pharmacy
- 1 April 2014
For widespread pharmacy-based testing to become a reality, policymakers and corporate pharmacy leadership would need to develop innovative solutions to the existing time pressures of pharmacists' behind-the-counter functions and absence of reimbursement for direct patient care services.
Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose
Overall the findings reveal factors at multiple levels which may play a role in likelihood of obtaining naloxone at the pharmacy, and can be used to inform interventions seeking to increase provision of pharmacy-based n aloxone.
Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.
- Traci C. Green, C. Davis, Z. Xuan, A. Walley, Jeffrey P. Bratberg
- Medicine, Political ScienceAmerican journal of public health
- 16 April 2020
Mandating the prescribing of naloxone quickly expands access to this life-saving medication for more people in more places after 90 days before and after they took effect in Arizona, Florida, Rhode Island, Vermont, and Virginia.